Modernizing the Regulatory System for Biotechnology Products; Notice of Second Public Meeting, 10858-10859 [2016-04583]
Download as PDF
10858
Federal Register / Vol. 81, No. 41 / Wednesday, March 2, 2016 / Notices
the review period for this PMN expires
May 25, 2016.
IV. What is EPA’s authority for taking
this action?
Section 5(c) of TSCA and 40 CFR
720.75(c) authorizes EPA to extend, for
good cause, the 90-day PMN review
period for additional periods not to
exceed in the aggregate 90 days. For this
PMN, EPA finds that there is good cause
to extend the review period. Based on
analysis, EPA may need to regulate this
new chemical substance and the Agency
needs an extension of the review period
to further investigate potential risk,
examine regulatory options, and prepare
the necessary documents, should
regulatory action be required.
Authority: 15 U.S.C. 2601 et seq.
Dated: February 25, 2016.
Greg Schweer,
Chief, New Chemicals Notice Management
Branch, Office of Pollution Prevention and
Toxics.
[FR Doc. 2016–04597 Filed 3–1–16; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[FDA–2015–N–3403; FRL–9943–08]
Modernizing the Regulatory System for
Biotechnology Products; Notice of
Second Public Meeting
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
Under the auspices of the
National Science and Technology
Council, EPA, along with the Office of
Science and Technology Policy (OSTP),
the Food and Drug Administration
(FDA), and the United States
Department of Agriculture (USDA) are
holding a second public meeting related
to the memorandum entitled,
‘‘Modernizing the Regulatory System for
Biotechnology Products,’’ issued by the
Executive Office of the President (EOP)
in July 2015. The purpose of the second
public meeting is to illustrate current
federal roles and responsibilities
regarding biotechnology products. The
docket, FDA–2015–N–3403, established
by FDA prior to the first public meeting
will continue to be used for this
interagency effort.
DATES: The meeting will be held on
March 9, 2016, from 9:30 a.m. to 1:00
p.m.
To request accommodation of a
disability, please immediately contact
the person listed under FOR FURTHER
INFORMATON CONTACT to give EPA as
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:10 Mar 01, 2016
Jkt 238001
much time as possible to process your
request.
ADDRESSES: The meeting will be held at
the EPA Region 6 Office at 1445 Ross
Avenue, Dallas, Texas 75202–2750.
FOR FURTHER INFORMATION CONTACT: For
general questions about the meeting,
contact Robert McNally, Biopesticides
and Pollution Prevention Division
(7511P), Office of Pesticide Programs,
Environmental Protection Agency, 1200
Pennsylvania Ave. NW., Washington,
DC 20460–0001; main telephone
number: (703) 305–7090; email address:
BPPDFRNotices@epa.gov. For questions
about the memorandum entitled,
‘‘Modernizing the Regulatory System for
Biotechnology Products,’’ or related
activities described in that
memorandum, contact the National
Science and Technology Council:
Emerging Technologies Interagency
Policy Coordination Committee, Office
of Science and Technology Policy,
Executive Office of the President,
Eisenhower Executive Office Building,
1650 Pennsylvania Ave. Washington,
DC 20504, 202–456–4444, online:
https://www.whitehouse.gov/webform/
contact-emerging-technologiesinteragency-policy-coordinatingcommittee-national-science-and.
SUPPLEMENTARY INFORMATION:
The second public meeting will be
held on March 9, 2016, from 9:30 a.m.
to 1:00 p.m. at EPA’s Region 6 Office in
Dallas, Texas. The second public
meeting will be used to illustrate
current federal roles and responsibilities
regarding biotechnology products. The
final meeting agenda will be placed in
the docket [FDA–2015–N–3403] as soon
as it is available.
The third public meeting will be held
on March 30, 2016, at the University of
California’s Davis Conference Center in
Davis, California and information about
that meeting, including an agenda and
information regarding how to register
will be placed in the docket and on the
USDA Web site prior to the meeting.
I. Background
Under the auspices of the National
Science and Technology Council, EPA,
FDA, USDA and OSTP (collectively
referred to as ‘‘we’’ in this Federal
Register document), held a public
meeting on October 30, 2015, to discuss
the Executive Office of the President
(EOP) memorandum entitled,
‘‘Modernizing the Regulatory System for
Biotechnology Products,’’ that was
issued in July 2015. The purpose of the
October 2015 meeting was to inform the
public about the activities described in
the July 2015 memorandum; invite oral
comments from interested parties; and
provide information about how to
submit written comments, data, or other
information to the docket. The October
meeting was the first of three public
engagement sessions on this topic.
On February 1, 2016, we announced
the dates and locations for the second
and third public engagement sessions:
(1) https://wcms.epa.gov/pesticides/
save-date-march-9-30-2016-publicmeetings-updating-coordinatedframework-regulation; (2) https://
www.fda.gov/NewsEvents/
MeetingsConferencesWorkshops/
ucm463783.htm; and (3) https://
www.aphis.usda.gov/aphis/ourfocus/
biotechnology/sa_stakeholder_
meetings/cf_meeting.
III. Meeting Materials, Transcripts and
Recorded Video
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
II. How can I participate in the March
9th meeting?
To participate in person or by webinar
via Adobe Connect, please register
online at https://www.epa.gov/
regulation-biotechnology-under-tscaand-fifra/modernizing-regulatorysystem-biotechnology-products.
Those registered will receive detailed
instructions with their confirmations
that explain how to access the meeting
via webinar or in person.
Any additional information and data
submitted voluntarily to us will become
part of the administrative record for this
activity and will be accessible to the
public in the docket [FDA–2015–N–
3403] at https://www.regulations.gov.
The transcript of the proceedings from
the public meeting will become part of
the administrative record for this
activity and will also be included in the
docket. Please be advised that as soon
as a transcript is available, it will be
accessible in the docket at https://
www.regulations.gov.
Transcripts and meeting materials
may also be viewed at the Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852. A
transcript will be available in either
hardcopy or on CD–ROM, after
submission of a Freedom of Information
request. Written requests are to be sent
to the FDA Division of Freedom of
Information, 5630 Fishers Lane, Rm.
1035, Rockville, MD 20857.
Additionally, we will live webcast and
record the public meeting. Once the
recorded video is available, it will be
accessible on EPA’s YouTube Channel.
E:\FR\FM\02MRN1.SGM
02MRN1
Federal Register / Vol. 81, No. 41 / Wednesday, March 2, 2016 / Notices
Dated: February 24, 2016.
Mark A. Hartman,
Acting Director, Biopesticides and Pollution
Prevention Division, Office of Pesticide
Programs.
[FR Doc. 2016–04583 Filed 3–1–16; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[EPAHQ–SFUND–2012–0104; FRL–9943–
10–OLEM]
Proposed Information Collection
Request; Comment Request;
Brownfields Program—
Accomplishment Reporting (Renewal)
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
The Environmental Protection
Agency is planning to submit an
information collection request (ICR),
‘‘Brownfields Program—
Accomplishment Reporting (Renewal)’’
(EPA ICR No. 2104.06, OMB Control No.
2050–0192) to the Office of Management
and Budget (OMB) for review and
approval in accordance with the
Paperwork Reduction Act (44 U.S.C.
3501 et seq.). Before doing so, EPA is
soliciting public comments on specific
aspects of the proposed information
collection as described below. This is a
proposed extension of the ICR, which is
currently approved through May 31,
2016. An Agency may not conduct or
sponsor and a person is not required to
respond to a collection of information
unless it displays a currently valid OMB
control number.
DATES: Comments must be submitted on
or before May 2, 2016.
ADDRESSES: Submit your comments,
referencing Docket ID No. EPA–HQ–
SFUND–2012–0104 online using
www.regulations.gov (our preferred
method) or by mail to: EPA Docket
Center, Environmental Protection
Agency, Mail Code 28221T, 1200
Pennsylvania Ave. NW., Washington,
DC 20460.
EPA’s policy is that all comments
received will be included in the public
docket without change including any
personal information provided, unless
the comment includes profanity, threats,
information claimed to be Confidential
Business Information (CBI) or other
information whose disclosure is
restricted by statute.
FOR FURTHER INFORMATION CONTACT:
Kelly Gorini, Office of Brownfields and
Land Revitalization, (5105T),
Environmental Protection Agency, 1200
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:10 Mar 01, 2016
Jkt 238001
Pennsylvania Ave. NW., Washington,
DC 20460; telephone number: (202)
566–1702; email address: gorini.kelly@
epa.gov.
SUPPLEMENTARY INFORMATION:
Supporting documents which explain in
detail the information that the EPA will
be collecting are available in the public
docket for this ICR. The docket can be
viewed online at www.regulations.gov
or in person at the EPA Docket Center,
WJC West, Room 3334, 1301
Constitution Ave. NW., Washington,
DC. The telephone number for the
Docket Center is 202–566–1744. For
additional information about EPA’s
public docket, visit https://www.epa.gov/
dockets.
Pursuant to section 3506(c)(2)(A) of
the PRA, EPA is soliciting comments
and information to enable it to: (i)
Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Agency, including
whether the information will have
practical utility; (ii) evaluate the
accuracy of the Agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(iii) enhance the quality, utility, and
clarity of the information to be
collected; and (iv) minimize the burden
of the collection of information on those
who are to respond, including through
the use of appropriate automated
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses. EPA will consider the
comments received and amend the ICR
as appropriate. The final ICR package
will then be submitted to OMB for
review and approval. At that time, EPA
will issue another Federal Register
notice to announce the submission of
the ICR to OMB and the opportunity to
submit additional comments to OMB.
Abstract: The Small Business Liability
Relief and Brownfields Revitalization
Act (Pub. L. 107–118) (‘‘the Brownfields
Amendments’’) was signed into law on
January 11, 2002. The Act amends the
Comprehensive Environmental
Response, Compensation, and Liability
Act (CERCLA), as amended, and
authorizes EPA to award cooperative
agreements to states, tribes, local
governments, and other eligible entities
to assess and clean up brownfield sites.
Under the Brownfields Amendments, a
brownfields site means real property,
the expansion, redevelopment, or reuse
of which may be complicated by the
presence or potential presence of a
hazardous substance, pollutant, or
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
10859
contaminant. For funding purposes,
EPA uses the term ‘‘brownfields
property(ies)’’ synonymously with the
term ‘‘brownfields sites.’’ The
Brownfields Amendments authorize
EPA to award several types of
cooperative agreements to eligible
entities on a competitive basis.
Under subtitle A of the Small
Business Liability Relief and
Brownfields Revitalization Act, states,
tribes, local governments, and other
eligible entities can receive assessment
cooperative agreements to inventory,
characterize, assess, and conduct
planning and community involvement
related to brownfields properties;
cleanup cooperative agreements to carry
out cleanup activities at brownfields
properties; cooperative agreements to
capitalize revolving loan funds and
provide subgrants for cleanup activities;
area-wide planning cooperative
agreements to develop revitalization
plans for brownfields; and
environmental workforce and
development job training and placement
programs. Under subtitle C of the Small
Business Liability Relief and
Brownfields Revitalization Act, states
and tribes can receive cooperative
agreements to establish and enhance
their response programs through the
four elements and meet the public
record requirements under the statute.
Cooperative agreement recipients
(‘‘recipients’’) have general reporting
and record keeping requirements as a
condition of their cooperative agreement
that result in burden. A portion of this
reporting and record keeping burden is
authorized under 2 CFR part 1500 and
identified in the EPA’s general grants
ICR (OMB Control Number 2030–0020).
EPA requires Brownfields program
recipients to maintain and report
additional information to EPA on the
uses and accomplishments associated
with funded brownfields activities. EPA
uses several forms to assist recipients in
reporting the information and to ensure
consistency of the information
collected. EPA uses this information to
meet Federal stewardship
responsibilities to manage and track
how program funds are being spent, to
evaluate the performance of the
Brownfields Cleanup and Land
Revitalization Program, to meet the
Agency’s reporting requirements under
the Government Performance Results
Act, and to report to Congress and other
program stakeholders on the status and
accomplishments of the program.
Form numbers: EPA ICR No. 2104.06,
OMB Control No. 2050–0192.
Respondents/affected entities: State/
local/tribal governments; Non-Profits.
E:\FR\FM\02MRN1.SGM
02MRN1
Agencies
[Federal Register Volume 81, Number 41 (Wednesday, March 2, 2016)]
[Notices]
[Pages 10858-10859]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04583]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[FDA-2015-N-3403; FRL-9943-08]
Modernizing the Regulatory System for Biotechnology Products;
Notice of Second Public Meeting
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Under the auspices of the National Science and Technology
Council, EPA, along with the Office of Science and Technology Policy
(OSTP), the Food and Drug Administration (FDA), and the United States
Department of Agriculture (USDA) are holding a second public meeting
related to the memorandum entitled, ``Modernizing the Regulatory System
for Biotechnology Products,'' issued by the Executive Office of the
President (EOP) in July 2015. The purpose of the second public meeting
is to illustrate current federal roles and responsibilities regarding
biotechnology products. The docket, FDA-2015-N-3403, established by FDA
prior to the first public meeting will continue to be used for this
interagency effort.
DATES: The meeting will be held on March 9, 2016, from 9:30 a.m. to
1:00 p.m.
To request accommodation of a disability, please immediately
contact the person listed under FOR FURTHER INFORMATON CONTACT to give
EPA as much time as possible to process your request.
ADDRESSES: The meeting will be held at the EPA Region 6 Office at 1445
Ross Avenue, Dallas, Texas 75202-2750.
FOR FURTHER INFORMATION CONTACT: For general questions about the
meeting, contact Robert McNally, Biopesticides and Pollution Prevention
Division (7511P), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-
0001; main telephone number: (703) 305-7090; email address:
BPPDFRNotices@epa.gov. For questions about the memorandum entitled,
``Modernizing the Regulatory System for Biotechnology Products,'' or
related activities described in that memorandum, contact the National
Science and Technology Council: Emerging Technologies Interagency
Policy Coordination Committee, Office of Science and Technology Policy,
Executive Office of the President, Eisenhower Executive Office
Building, 1650 Pennsylvania Ave. Washington, DC 20504, 202-456-4444,
online: https://www.whitehouse.gov/webform/contact-emerging-technologies-interagency-policy-coordinating-committee-national-science-and.
SUPPLEMENTARY INFORMATION:
I. Background
Under the auspices of the National Science and Technology Council,
EPA, FDA, USDA and OSTP (collectively referred to as ``we'' in this
Federal Register document), held a public meeting on October 30, 2015,
to discuss the Executive Office of the President (EOP) memorandum
entitled, ``Modernizing the Regulatory System for Biotechnology
Products,'' that was issued in July 2015. The purpose of the October
2015 meeting was to inform the public about the activities described in
the July 2015 memorandum; invite oral comments from interested parties;
and provide information about how to submit written comments, data, or
other information to the docket. The October meeting was the first of
three public engagement sessions on this topic.
On February 1, 2016, we announced the dates and locations for the
second and third public engagement sessions: (1) https://wcms.epa.gov/pesticides/save-date-march-9-30-2016-public-meetings-updating-coordinated-framework-regulation; (2) https://www.fda.gov/NewsEvents/MeetingsConferencesWorkshops/ucm463783.htm; and (3) https://www.aphis.usda.gov/aphis/ourfocus/biotechnology/sa_stakeholder_meetings/cf_meeting.
The second public meeting will be held on March 9, 2016, from 9:30
a.m. to 1:00 p.m. at EPA's Region 6 Office in Dallas, Texas. The second
public meeting will be used to illustrate current federal roles and
responsibilities regarding biotechnology products. The final meeting
agenda will be placed in the docket [FDA-2015-N-3403] as soon as it is
available.
The third public meeting will be held on March 30, 2016, at the
University of California's Davis Conference Center in Davis, California
and information about that meeting, including an agenda and information
regarding how to register will be placed in the docket and on the USDA
Web site prior to the meeting.
II. How can I participate in the March 9th meeting?
To participate in person or by webinar via Adobe Connect, please
register online at https://www.epa.gov/regulation-biotechnology-under-tsca-and-fifra/modernizing-regulatory-system-biotechnology-products.
Those registered will receive detailed instructions with their
confirmations that explain how to access the meeting via webinar or in
person.
III. Meeting Materials, Transcripts and Recorded Video
Any additional information and data submitted voluntarily to us
will become part of the administrative record for this activity and
will be accessible to the public in the docket [FDA-2015-N-3403] at
https://www.regulations.gov. The transcript of the proceedings from the
public meeting will become part of the administrative record for this
activity and will also be included in the docket. Please be advised
that as soon as a transcript is available, it will be accessible in the
docket at https://www.regulations.gov.
Transcripts and meeting materials may also be viewed at the
Division of Dockets Management (HFA-305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. A transcript will be
available in either hardcopy or on CD-ROM, after submission of a
Freedom of Information request. Written requests are to be sent to the
FDA Division of Freedom of Information, 5630 Fishers Lane, Rm. 1035,
Rockville, MD 20857. Additionally, we will live webcast and record the
public meeting. Once the recorded video is available, it will be
accessible on EPA's YouTube Channel.
[[Page 10859]]
Dated: February 24, 2016.
Mark A. Hartman,
Acting Director, Biopesticides and Pollution Prevention Division,
Office of Pesticide Programs.
[FR Doc. 2016-04583 Filed 3-1-16; 8:45 am]
BILLING CODE 6560-50-P